IA
AMRX icon

IFP Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

IFP Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Sell
689
-148
-18% -$2.03K ﹤0.01% 3279
2026
Q1 		$10.4K Buy
837
+148
+21% +$1.99K ﹤0.01% 3132
2025
Q4 		$8.68K Buy
689
+21
+3% +$240 ﹤0.01% 3134
2025
Q3 		$6.69K Sell
668
-26
-4% -$233 ﹤0.01% 3100
2025
Q2 		$5.62K Buy
+694
New +$5.23K ﹤0.01% 3292
2025
Q1 		– Hold
0
– – – 3936
2024
Q4 		– Hold
0
– – – 4143
2023
Q1 		– Sell
-99,211
Closed -$1.97M – 3390
2022
Q4 		$1.97M Buy
99,211
+3,058
+3% +$6.86K 0.05% 373
2022
Q3 		$1.91M Buy
96,153
+94,378
+5,317% +$264K 0.05% 421
2022
Q2 		$35K Hold
1,775
– – ﹤0.01% 2406
2022
Q1 		$35K Buy
1,775
+1,250
+238% +$5.54K ﹤0.01% 2406
2021
Q4 		$3K Hold
525
– – ﹤0.01% 2637
2021
Q3 		$3K Buy
525
+150
+40% +$755 ﹤0.01% 2694
2021
Q2 		$2K Hold
375
– – ﹤0.01% 2709
2021
Q1 		$3K Buy
+375
New +$2.08K ﹤0.01% 2535
2020
Q3 		– Sell
-2,000
Closed -$8.55K – 2838
2020
Q2 		$9K Buy
+2,000
New +$8.24K ﹤0.01% 1850
2018
Q4 		– Sell
-5,748
Closed -$128K – 3508
2018
Q3 		$128K Hold
5,748
– – 0.01% 1332
2018
Q2 		$94K Buy
+5,748
New +$101K ﹤0.01% 1517

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

IFP Advisors's AMRX Position: Q2 2026 in Review

IFP Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, selling an estimated $2.03K and leaving 689 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

IFP Advisors first reported a position in AMRX in Q2 2018 and has held it in 16 quarters since. The position peaked at $1.97M in Q4 2022. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • IFP Advisors held 689 shares of Amneal Pharmaceuticals worth $11.9K as of Q2 2026.
  • IFP Advisors sold 148 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.03K.
  • Amneal Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3279 holding.
  • IFP Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
  • IFP Advisors's Amneal Pharmaceuticals position peaked at $1.97M in Q4 2022.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.